PCSK9 gene editing - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Persimmon plc targets around 12,500 home completions in 2026 after stronger first-half volumes, even as rising construction, energy and materials costs threaten margins across the United Kingdom housebuilding sector. Representative image.

Persimmon plc raises 2026 home completion target as £50m inflation hit threatens margin recovery

Volodymyr Zelenskyy’s first official visit to Serbia is deepening Kyiv-Belgrade trade and political ties even as Serbia maintains energy links with Russia. Representative image.

Zelenskyy visits Russia-friendly Serbia as Kyiv strikes deepen Moscow’s oil infrastructure crisis

Representative image: An Arko Corp convenience store fuel pump and forecourt in the United States, reflecting the Q2 2026 revenue beat, the 5.7% drop in retail same-store fuel gallons and the ARKO Petroleum Corp agreement to acquire U.S. Petroleum Partners for $205 million.

Arko Corp Q2 revenue tops $2.35bn as APC agrees to $205m USPP acquisition

Lexeo’s second cardiac gene therapy gains FDA support ahead of year-end update

Read More

General business news

Lilly to expand into cardiovascular gene editing with Verve Therapeutics acquisition

Eli Lilly’s $1.3B acquisition of Verve Therapeutics targets breakthrough one-time gene therapies for high-risk cardiovascular patients. Read more.

byPallavi Madhiraju

June 17, 2025

web analytics